Smart Money Alert

Onesource Specialty Pharma Limited

DecreasedBulk Deal

ONESOURCEPharmaceuticalsMarket Cap₹17K Cr

Value

₹162 Cr

10,57,902

Price

₹1,530

Nova Global

Foreign Investor

The move

Nova Global sold 10,57,902 shares of Onesource Specialty Pharma Limited for ₹161.86 crore at ₹1,530.00 apiece in a bulk deal.

About Onesource Specialty Pharma Limited

Visit stock

A specialist pharmaceutical company engaged in the research, development, and manufacturing of biological drug products in injectable formats for therapeutic use. OneSource Specialty Pharma provides comprehensive contract development and manufacturing organization services spanning all phases of preclinical and clinical development, alongside commercial supply of biologics to domestic and international pharmaceutical clients and healthcare providers.

About Nova Global

Visit investor

Nova Global Opportunities Fund PCC is a foreign portfolio investor that is an active anchor investor in Indian SME IPOs. It has backed offerings across sectors including electric equipment, power and energy, infrastructure, and logistics.

Get the next move the moment it happens.

Follow Nova Global and Onesource Specialty Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Onesource Specialty Pharma Limited shareholders Nova Global's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Onesource Specialty Pharma Limited

Amansa HoldingsDecreased

Amansa Holdings decreased its stake in Onesource Specialty Pharma Limited from 3.47% to 1.86%, selling 1,841,289 shares. The value of the remaining shares is ₹334.8 Cr at ₹1571.30 apiece.

22 Jul 2026

FidelityNew position

Fidelity bought 20,20,423 shares of Onesource Specialty Pharma Limited, a 1.76% stake, worth ₹334.02 Cr at ₹1653.20 apiece.